Germany to bring in new procedure for unapproved drugs for compassionate use
This article was originally published in Scrip
Germany is to introduce new procedures that will allow pharmaceutical companies to set up compassionate use programmes for using unapproved drugs in seriously ill patients. The new regulations should offer greater legal security for firms and doctors and will see companies pay for the drugs provided via the programmes.
You may also be interested in...
While information sharing is key to cross-country collaborations on access to medicines and can lead to major benefits, it is hard to sell to political leaders and the media, says a report from the World Health Organization’s regional office for Europe.
The European Commission says it will publish its review of the EU orphan drug legislation in the coming days.
The UK has formally withdrawn its ratification of the Unified Patent Court Agreement, adding to the uncertainty over its future.